Moderna requests an EUA for its COVID-19 booster for all adults; the Securities and Exchange Commission (SEC) is investigating claims regarding data for Cassava Sciences’ Alzheimer drug; Florida legislators approved a bill barring private companies from issuing COVID-19 vaccine mandates.
Moderna has asked the FDA for emergency use authorization(EUA)for booster doses of its COVID-19 vaccine for all adults, seeking to expand the number of people who can receive a third dose, according to The Hill. The FDA previously granted an EUA for Moderna’s booster dose to be given at least 6 months after the second dose to people 65 years or older and adults at high risk for severe COVID-19 due to underlying conditions or their living or work environments. The request comes as the FDA is expected to authorize Pfizer’s booster dose for for all adults ahead of a CDC advisory meeting on Friday, November 19. CDC Director Rochelle Walensky, MD, MPH, will have the final say on whether all adults can get a third dose of Pfizer or Moderna’s vaccines.
According to The Wall Street Journal, the Securities and Exchange Commission (SEC) is investigating claims that Cassava Sciences manipulated research results of its experimental Alzheimer drug, simulfilam. Cassava disclosed in a securities filing that it is cooperating with federal investigators but did not name an agency. The National Institutes of Health, which has been providing $20 million in grants to Cassava and its academic collaborators for drug development since 2015, is also investigating the claims. The accusations appeared in a public petition written by 2 physicians to the FDA asking it to suspend Cassava’s clinical trials, saying they doubted Cassava’s research due to some studies using duplicated images from other sources.
Florida Republican legislators approved a bill that would block businesses from issuing COVID-19 vaccine mandates, according to The Associated Press. Under the bill, private companies would be barred from having vaccine mandates unless they allow workers to opt out for medical reasons, religious beliefs, immunity based on previous infection, regular testing, or an agreement to wear protective gear. The bill would also fine businesses that fire a worker without allowing the exemptions, bars schools from issuing vaccine mandates, and allows parents to sue schools with mask requirements.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More